Wust P - Search Results

1

Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Schär C, Sumila M, Zaugg K, Guckenberger M, Ost P, Reuter C, Bosetti DG, Khanfir K, Gomez S, Wust P, Thalmann GN, Aebersold DM; Swiss Group for Clinical Cancer Research (SAKK). Ghadjar P, et al. Among authors: wust p. Eur Urol. 2021 Sep;80(3):306-315. doi: 10.1016/j.eururo.2021.05.033. Epub 2021 Jun 14. Eur Urol. 2021. PMID: 34140144 Clinical Trial.

2

Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.

Höcht S, Hammad R, Thiel HJ, Wiegel T, Siegmann A, Willner J, Wust P, Herrmann T, Eble M, Flentje M, Carstens D, Bottke D, Neumann P, Hinkelbein W. Höcht S, et al. Among authors: wust p. Strahlenther Onkol. 2004 Jan;180(1):15-20. doi: 10.1007/s00066-004-1130-8. Strahlenther Onkol. 2004. PMID: 14704840

3

Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.

Wust P, von Borczyskowski DW, Henkel T, Rosner C, Graf R, Tilly W, Budach V, Felix R, Kahmann F. Wust P, et al. Radiother Oncol. 2004 Oct;73(1):39-48. doi: 10.1016/j.radonc.2004.08.003. Radiother Oncol. 2004. PMID: 15465144

4

Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0.

Tilly W, Gellermann J, Graf R, Hildebrandt B, Weissbach L, Budach V, Felix R, Wust P. Tilly W, et al. Among authors: wust p. Strahlenther Onkol. 2005 Jan;181(1):35-41. doi: 10.1007/s00066-005-1296-8. Strahlenther Onkol. 2005. PMID: 15660191 Clinical Trial.

5

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial.

Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD. Budach V, et al. Among authors: wust p. J Clin Oncol. 2005 Feb 20;23(6):1125-35. doi: 10.1200/JCO.2005.07.010. J Clin Oncol. 2005. PMID: 15718308 Clinical Trial.

6

A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas.

Graf R, Hildebrandt B, Tilly W, Riess H, Felix R, Budach V, Wust P. Graf R, et al. Among authors: wust p. BMC Cancer. 2006 Feb 1;6:30. doi: 10.1186/1471-2407-6-30. BMC Cancer. 2006. PMID: 16451730 Free PMC article.

7

Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.

Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, Waldöfner N, Scholz R, Jordan A, Loening SA, Wust P. Johannsen M, et al. Among authors: wust p. Eur Urol. 2007 Dec;52(6):1653-61. doi: 10.1016/j.eururo.2006.11.023. Epub 2006 Nov 17. Eur Urol. 2007. PMID: 17125906 Clinical Trial.

8

Postimplantation analysis enables improvement of dose-volume histograms and reduction of toxicity for permanent seed implantation.

Wust P, Postrach J, Kahmann F, Henkel T, Graf R, Cho CH, Budach V, Böhmer D. Wust P, et al. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):28-35. doi: 10.1016/j.ijrobp.2007.09.011. Epub 2007 Nov 26. Int J Radiat Oncol Biol Phys. 2008. PMID: 18037588

9

Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy.

Graf R, Wust P, Budach V, Boehmer D. Graf R, et al. Among authors: wust p. Radiat Oncol. 2009 Apr 27;4:13. doi: 10.1186/1748-717X-4-13. Radiat Oncol. 2009. PMID: 19397824 Free PMC article. Clinical Trial.

10

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.

Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A. Maier-Hauff K, et al. Among authors: wust p. J Neurooncol. 2011 Jun;103(2):317-24. doi: 10.1007/s11060-010-0389-0. Epub 2010 Sep 16. J Neurooncol. 2011. PMID: 20845061 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page